tradmap

SPTX Earnings Seaport Therapeutics, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Quarterly results

Diluted EPS (quarterly)
-$12 -$6 $0 Q1 '25 Q2 '25 Q1 '26 Q2 '26
EPS
Net income (quarterly)
-$63M -$31M $0 Q1 '25 Q2 '25 Q1 '26 Q2 '26
Net income
Return on equity (quarterly)
-15% 11% 36% 0% Q1 '25 Q2 '25 Q1 '26 Q2 '26
ROE

Reported EPS history

1–4 of 4
Q2 20262026-06-30-4.602026-08-0310-Q
Q1 20262026-03-31-10.342026-06-0810-Q
Q2 20262025-06-30-12.052026-08-0310-Q
Q1 20262025-03-31-5.652026-06-0810-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.